Annals of the New York Academy of Sciences · 1986 · 22 citations · 12 references
MedicineInternal MedicineRadiologyDiagnostic ImagingDiagnostic RadiologyPulmonologyPulmonary AssessmentPulmonary ImagingPulmonary Nuclear ImagingPulmonary PathologyRespiratory DiseaseActive Disease DifferentiationBiopsy In SarcoidosisClinical Activity ScoringProgressive Disease AssessmentProgressive Disease Quantification
Gallium-67 scans have been widely employed in patients with sarcoidosis as a means of indicating alveolitis and the need for corticosteroid therapy. Observation of 32 patients followed 3 or more years after gallium scans showed no correlation between findings and later course: of 10 patients with pulmonary uptake, 7 recovered with minor residuals; of 18 patients with mediastinal of extrathoracic uptake, 10 had persistent or progressive disease; of 4 patients with negative initial scans, 2 had later progression. The value of gallium-67 scans as an aid to diagnosis was studied in 40 patients with extrapulmonary sarcoidosis. In 12 patients, abnormal lacrimal, nodal, or pulmonary uptake aided in selection of biopsy sites. Gallium-67 scans and serum ACE levels were compared in 97 patients as indices of clinical activity. Abnormal gallium-67 uptake was observed in 96.3% of the tests in active disease, and ACE level elevation occurred in 56.3%. In 24 patients with inactive or recovered disease, abnormal gallium-67 uptake occurred in 62.5% and ACE level elevation in 37.5%. Gallium-67 scans have a limited but valuable role in the diagnosis and management of sarcoidosis.
12
Assessment of Activity in Sarcoidosis
H Klech, H Köhn, F Kummer et al. · CHEST Journal · 1982 · 93 citations
Medicine, Immunology, Pathology +4